| Type | MGI:General | Description | after stimulation with anti-CD3 and CTLA-4, wild-type T cells become anergic and produce very little IL-2, but mutant cells produce more IL-2; treatment of mutant cells with Dgka inhibitor results in levels of IL-2 production similar to those in anti-CD3-treated wild-type cells receiving CD28 costimulation |
